AVITA MEDICAL INC (RCEL) Stock Income Statement
NASDAQ:RCEL - US05380C1027 - Common Stock
4.24 USD
-0.02 (-0.47%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 74.88M | 64.25M | 50.14M | 34.42M | 29.23M | |||
| Cost Of Goods | -218.79M | 8.61M | 7.56M | 5.67M | 5.72M | |||
| Gross Profit | 293.68M | 55.64M | 42.58M | 28.76M | 23.51M | |||
| Operating Expenses | 109.95M | 111.64M | 84.93M | 55.88M | 49.82M | |||
| Research and Development | 21.68M | 20.36M | 20.82M | 13.86M | 14.82M | |||
| Selling, General, and Administrative Expenses | 88.27M | 91.28M | 65.54M | 45.24M | 37.06M | |||
| Operating Income | 183.72M | -56.00M | -42.35M | -27.13M | -26.31M | |||
| Interest Income/Expense | -5.14M | -5.36M | -1.14M | -20.00K | -20.00K | |||
| Other Income/Expense | 310.00K | 163.00K | 8.48M | 890.00K | 20.00K | |||
| Non Recurring Items | -230.46M | -594.00K | -308.00K | -380.00K | -230.00K | |||
| Income Before Taxes | -51.57M | -61.79M | -35.31M | -26.63M | -26.55M | |||
| Income Tax | 3.00K | 54.00K | 66.00K | 40.00K | 40.00K | |||
| Net Income | -51.57M | -61.84M | -35.38M | -26.67M | -26.58M | |||
| EBITDA | 185.52M | -54.87M | -41.72M | -26.56M | -25.59M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.97 | -2.39 | -1.40 | -1.07 | -1.17 | |||
| Non GAAP EPS | -1.97 | -2.39 | -1.40 | -1.07 | -1.17 | |||
| Statistics | ||||||||
| Gross Profit Margin | 392.18% | 86.60% | 84.93% | 83.56% | 80.43% | |||
| Profit Margin | -68.87% | -96.26% | -70.56% | -77.48% | -90.93% | |||
| Operating Profit Margin | 245.35% | -87.16% | -84.45% | -78.82% | -90.01% | |||
All data in USD